ADAPTIMMUNE THERAPEUTICS PLC Retained Earnings
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Retained Earnings of -$1.17 billion as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-08-13
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$1.17B.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$1.14B.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$1.09B.
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$1.02B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-06-30 | -$1.17B 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$1.14B 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$1.09B 10-Q · filed 2025-08-13 |
| 2024-09-30 | -$1.02B 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$1.00B 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$1.07B 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$1.02B 10-K · filed 2025-03-24 |
| 2023-09-30 | -$975.26M 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$929.65M 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$908.27M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$909.30M 10-K · filed 2024-03-06 |
| 2022-09-30 | -$880.05M 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$838.63M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$794.11M 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$743.85M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$704.99M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$662.59M 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$623.52M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$585.76M 10-K · filed 2022-03-14 |
| 2020-09-30 | -$549.14M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$513.71M 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$483.83M 10-Q · filed 2020-05-14 |
| 2019-12-31 | -$455.66M 10-K · filed 2021-02-25 |
| 2019-09-30 | -$426.30M 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$387.00M 10-Q · filed 2019-08-01 |
| 2019-03-31 | -$345.91M 10-Q · filed 2019-05-06 |
| 2018-12-31 | -$318.50M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$282.33M 10-Q · filed 2018-11-06 |
| 2018-06-30 | -$287.57M 10-Q · filed 2018-08-02 |
| 2018-03-31 | -$244.06M 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$231.63M 10-K · filed 2019-02-27 |
| 2017-09-30 | -$204.37M 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$203.49M 10-Q · filed 2017-08-03 |
| 2017-03-31 | -$183.27M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$161.49M 10-K · filed 2018-03-15 |
| 2016-09-30 | -$146.08M 10-Q · filed 2016-11-10 |
| 2016-06-30 | -$127.58M 10-Q · filed 2016-08-08 |
| 2016-03-31 | -$105.49M 10-Q · filed 2016-05-12 |
| 2015-12-31 | -$89.91M 10-K · filed 2017-03-13 |
| 2015-06-30 | -$66.91M 10-K · filed 2017-03-13 |
| 2014-06-30 | -$30.12M 8-K · filed 2016-07-08 |